CN103766904A - Preparation of capsule with function of lowering lipid and facilitating feces excretion and application of capsule - Google Patents
Preparation of capsule with function of lowering lipid and facilitating feces excretion and application of capsule Download PDFInfo
- Publication number
- CN103766904A CN103766904A CN201410029675.9A CN201410029675A CN103766904A CN 103766904 A CN103766904 A CN 103766904A CN 201410029675 A CN201410029675 A CN 201410029675A CN 103766904 A CN103766904 A CN 103766904A
- Authority
- CN
- China
- Prior art keywords
- natto
- capsule
- asparagus
- parts
- powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title abstract description 10
- 150000002632 lipids Chemical class 0.000 title abstract description 5
- 230000029142 excretion Effects 0.000 title abstract 2
- 210000003608 fece Anatomy 0.000 title abstract 2
- 235000013557 nattō Nutrition 0.000 claims abstract description 50
- 239000000843 powder Substances 0.000 claims abstract description 49
- 235000013325 dietary fiber Nutrition 0.000 claims abstract description 38
- 235000005340 Asparagus officinalis Nutrition 0.000 claims abstract description 36
- 230000000694 effects Effects 0.000 claims abstract description 19
- 239000003814 drug Substances 0.000 claims abstract description 9
- 239000000463 material Substances 0.000 claims abstract description 9
- 206010010774 Constipation Diseases 0.000 claims abstract description 6
- 208000024172 Cardiovascular disease Diseases 0.000 claims abstract description 5
- 208000026106 cerebrovascular disease Diseases 0.000 claims abstract description 5
- 230000002526 effect on cardiovascular system Effects 0.000 claims abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 4
- 229940079593 drug Drugs 0.000 claims abstract description 3
- 241000234427 Asparagus Species 0.000 claims description 35
- 244000063299 Bacillus subtilis Species 0.000 claims description 17
- 235000014469 Bacillus subtilis Nutrition 0.000 claims description 17
- 230000036541 health Effects 0.000 claims description 15
- 244000068988 Glycine max Species 0.000 claims description 13
- 235000010469 Glycine max Nutrition 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 235000010575 Pueraria lobata Nutrition 0.000 claims description 11
- 244000046146 Pueraria lobata Species 0.000 claims description 11
- 102000004882 Lipase Human genes 0.000 claims description 10
- 108090001060 Lipase Proteins 0.000 claims description 10
- 239000004367 Lipase Substances 0.000 claims description 10
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims description 10
- 235000019421 lipase Nutrition 0.000 claims description 10
- 102000004190 Enzymes Human genes 0.000 claims description 9
- 108090000790 Enzymes Proteins 0.000 claims description 9
- 230000001954 sterilising effect Effects 0.000 claims description 9
- 238000012545 processing Methods 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000004382 Amylase Substances 0.000 claims description 7
- 102000013142 Amylases Human genes 0.000 claims description 7
- 108010065511 Amylases Proteins 0.000 claims description 7
- 235000019418 amylase Nutrition 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 230000008569 process Effects 0.000 claims description 7
- 241000894006 Bacteria Species 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- 239000009429 Ginkgo biloba extract Substances 0.000 claims description 5
- 108091005804 Peptidases Proteins 0.000 claims description 5
- 239000004365 Protease Substances 0.000 claims description 5
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 claims description 5
- 230000008859 change Effects 0.000 claims description 5
- 238000001035 drying Methods 0.000 claims description 5
- 229940068052 ginkgo biloba extract Drugs 0.000 claims description 5
- 238000000227 grinding Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 3
- 238000011081 inoculation Methods 0.000 claims description 3
- 238000002791 soaking Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- CPGCVOVWHCWVTP-LJAQVGFWSA-N (S)-nonacosan-10-ol Chemical compound CCCCCCCCCCCCCCCCCCC[C@@H](O)CCCCCCCCC CPGCVOVWHCWVTP-LJAQVGFWSA-N 0.000 claims description 2
- CPGCVOVWHCWVTP-UHFFFAOYSA-N celidoniol Natural products CCCCCCCCCCCCCCCCCCCC(O)CCCCCCCCC CPGCVOVWHCWVTP-UHFFFAOYSA-N 0.000 claims description 2
- 235000016709 nutrition Nutrition 0.000 abstract description 6
- 230000035764 nutrition Effects 0.000 abstract description 6
- 241000219780 Pueraria Species 0.000 abstract description 3
- 230000029087 digestion Effects 0.000 abstract description 2
- YLKVIMNNMLKUGJ-FPLPWBNLSA-N (15:1)-Cardanol Chemical compound CCCCCC\C=C/CCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-FPLPWBNLSA-N 0.000 abstract 1
- YLKVIMNNMLKUGJ-UHFFFAOYSA-N 3-Delta8-pentadecenylphenol Natural products CCCCCCC=CCCCCCCCC1=CC=CC(O)=C1 YLKVIMNNMLKUGJ-UHFFFAOYSA-N 0.000 abstract 1
- 244000003416 Asparagus officinalis Species 0.000 abstract 1
- 230000003416 augmentation Effects 0.000 abstract 1
- 230000003796 beauty Effects 0.000 abstract 1
- 210000000481 breast Anatomy 0.000 abstract 1
- 230000003247 decreasing effect Effects 0.000 abstract 1
- 230000000968 intestinal effect Effects 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 235000008100 Ginkgo biloba Nutrition 0.000 description 6
- 241000699666 Mus <mouse, genus> Species 0.000 description 6
- 230000013872 defecation Effects 0.000 description 6
- 229940088598 enzyme Drugs 0.000 description 6
- HVAUUPRFYPCOCA-AREMUKBSSA-N 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](OC(C)=O)COP([O-])(=O)OCC[N+](C)(C)C HVAUUPRFYPCOCA-AREMUKBSSA-N 0.000 description 5
- 108010003541 Platelet Activating Factor Proteins 0.000 description 5
- 241000700159 Rattus Species 0.000 description 5
- 244000005700 microbiome Species 0.000 description 5
- 229940086319 nattokinase Drugs 0.000 description 5
- 108010073682 nattokinase Proteins 0.000 description 5
- 150000003626 triacylglycerols Chemical class 0.000 description 5
- 244000194101 Ginkgo biloba Species 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 239000000470 constituent Substances 0.000 description 4
- 238000011049 filling Methods 0.000 description 4
- 239000013642 negative control Substances 0.000 description 4
- 239000002504 physiological saline solution Substances 0.000 description 4
- 210000002966 serum Anatomy 0.000 description 4
- 241000699670 Mus sp. Species 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000001809 melena Anatomy 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 238000004321 preservation Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 235000011201 Ginkgo Nutrition 0.000 description 2
- 241000218628 Ginkgo Species 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- MOLPUWBMSBJXER-YDGSQGCISA-N bilobalide Chemical compound O([C@H]1OC2=O)C(=O)[C@H](O)[C@@]11[C@@](C(C)(C)C)(O)C[C@H]3[C@@]21CC(=O)O3 MOLPUWBMSBJXER-YDGSQGCISA-N 0.000 description 2
- 210000004204 blood vessel Anatomy 0.000 description 2
- 239000007963 capsule composition Substances 0.000 description 2
- 210000003169 central nervous system Anatomy 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 239000001963 growth medium Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 235000001497 healthy food Nutrition 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 235000020795 whole food diet Nutrition 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000001738 Nervous System Trauma Diseases 0.000 description 1
- 235000014676 Phragmites communis Nutrition 0.000 description 1
- 108010022999 Serine Proteases Proteins 0.000 description 1
- 102000012479 Serine Proteases Human genes 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 230000004308 accommodation Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 210000001367 artery Anatomy 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 210000001772 blood platelet Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 230000007885 bronchoconstriction Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000007910 chewable tablet Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000007599 discharging Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000012055 fruits and vegetables Nutrition 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 229930184727 ginkgolide Natural products 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 208000028412 nervous system injury Diseases 0.000 description 1
- 210000003061 neural cell Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- KJFMBFZCATUALV-UHFFFAOYSA-N phenolphthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2C(=O)O1 KJFMBFZCATUALV-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000036186 satiety Effects 0.000 description 1
- 235000019627 satiety Nutrition 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000009777 vacuum freeze-drying Methods 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/50—Fermented pulses or legumes; Fermentation of pulses or legumes based on the addition of microorganisms
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
- A23L29/206—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents of vegetable origin
- A23L29/212—Starch; Modified starch; Starch derivatives, e.g. esters or ethers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
Abstract
The invention discloses a capsule with function of lowering lipid and facilitating feces excretion and a preparation method of the capsule. The capsule comprises the following raw medicines in parts by weight: 40-50 parts of natto powder, 35-40 parts of dietary fiber, 5-10 parts of a ginkgol biloba extract, 10-15 parts of pueraria root powder and pharmaceutically acceptable auxiliary materials. The capsule product is good in nutrition and healthcare function, and simple and convenient to take; the freeze-dried natto retains nutrition and function components of the natto to the greatest extent; the product has the effects of preventing and treating cardiovascular and cerebrovascular diseases, changing human intestinal flora ecology, facilitating digestion, relieving constipation, lowering lipid, reducing pressure, decreasing internal heat, clearing heat and removing toxicity; the product also takes the special effects on beauty fitness, breast augmentation, and the like of women; the influence of the natto, the pueraria root powder and asparagus on taste of consumers can be avoided.
Description
Technical field
The invention belongs to health products (healthy food) manufacture field, relate to a kind of preparation and application thereof with lipopenicillinase, bowel relaxing functions capsule and use.
Background technology
Natto is a kind of fermented food that utilizes Bacillus natto to obtain in soybean top fermentation, is deeply subject to liking of japanese people in Japan.Fermented soya bean with China are the same, and natto has had the history of more than one thousand years.Within 1987, the Japanese physiology professor doctor of Xu Jian foreign firm finds Nattokinase from natto, and confirms that Nattokinase has after good thrombus effect, and natto gains considerable fame especially.Nattokinase is a kind of serine protease that Bacillus natto produces in the process of fermentation, research shows, Nattokinase can effectively be removed the thrombus in blood of human body, and hypertension, aging, apoplexy, muscle cramp and cardiovascular and cerebrovascular disease are also had to good curative effect, and have no side effect, Bacillus natto also produces a lot of other materials as vitamin K, protease, polypeptide etc. in the process of fermenting simultaneously, these materials are all conducive to health, and therefore Nattokinase is developed to middle-aged and old health foods by numerous companies.
Bacillus natto is subspecies for bacillus subtilis; it is a kind of beneficial bacterium acidproof, heat-resistant quality that has; under hydrochloric acid in gastric juice, four hours survival rates are 100%, have powerful pathogen and suppress ability, self do not have pathogenic simultaneously; in the middle of various beneficial bacterium; to environment tolerance one of the bacterial classification of small intestine that preferably can go directly, can change the human enteric bacteria state of growing thickly after oral, help digest function normalization; so that defecation is smooth and easy, maintain body physiological environmental protection.
Dietary fiber is that polysaccharide and the wood that can not be decomposed by human body alimentary canal ferment are planted element, has the effect that absorbs moisture content in digestive system.Dietary fiber can increase the food volume in enteron aisle and stomach, can increase satiety; Enterogastric peristalsis can be promoted again, constipation can be alleviated; Dietary fiber also can adsorb the harmful substance in enteron aisle to discharge simultaneously.Asparagus has another name called asparagus, is rich in several amino acids, protein and vitamin, and its content all, higher than general fruits and vegetables, is enjoyed the laudatory title of " kings of vegetables " in the international market.Along with growing to asparagus demand of people, the processing of asparagus leftover bits and pieces also becomes a large problem.From asparagus leftover bits and pieces, extract and prepare dietary fiber, not only can be salvaged, improve asparagus added value, can also avoid asparagus leftover bits and pieces to huddle and leave about the problem of environmental pollution causing.
Ginkgo biloba p.e be leaf take ginkgo as raw material, adopt suitable solvent, a series products of the active ingredient enrichment of extraction.The medical value of ginkgo biloba p.e is very extensive with application.Ginkgo biloba p.e can promote the circulation of brain and health limbs simultaneously.An its main health care suppresses the material that one is called platelet activating factor (PAF) exactly, and PAF is a kind of medium discharging from cell, and it can cause platelet aggregation (being deposited in together).The PAF of high-load can cause neural cell injury, and central nervous system CBF reduces, inflammation, and bronchoconstriction.Closely similar with free radical, high PAF level also can cause aging.Ginkgolides and Bilobalide can protect the nerve cell of central nervous system injury-free in period at ischemic (in-vivo tissue lacks oxygen).This function may be able to have to suffering from the patient of apoplexy the effect of supplemental treatment.Except suppressing thrombocyte adhesiveness, ginkgo biloba extract regulates antiotasis and elastic force.It can make blood vessel circulation more efficient.This lifting cycle efficieny effect has same purpose to the trunk in the circulatory system (artery) and less blood vessel (capillary).
Kudzu-vine root powder is the starch extracting from Wild Pueraria, there is lipopenicillinase, step-down, fall fire, clearing heat and detoxicating, rise positive expelling pathogenic factors from muscles and skin, spasmolysis and analgesia, promoting eruption antidiarrheal, increase brain and crown blood sugar, improve the effects such as brain microcirculation, it is the important source material of preventing and treating the medicine of the various diseases such as hypertension, high fat of blood, coronary heart diseases and angina pectoris, diabetes, cerebral thrombus, enterogastritis, women's cosmetology and health, chest enlarge etc. are had to special efficacy, be the wholefood that nutritive value is very high simultaneously.
In recent years, the processing of natto product has development faster, and Chewable Tablets, natto drink powder, Notto beverage, natto yoghourt are come out one after another.Further investigation reveals that, these products have certain nutritive value, but market reaction is flat, traces it to its cause, and be mainly that the natto local flavor that Japan produces is difficult to Chinese's acceptance, and independent natto powder effect are limited.The present invention has gone out to have the natto dietary fiber capsule product of lipopenicillinase, ease constipation defecation with natto powder mixed developing with kudzu-vine root powder, ginkgo biloba extract, dietary fiber.
Summary of the invention
The object of the present invention is to provide and a kind ofly contain wholefood that abundant nutrition is worth as raw material take multiple, a kind of capsule with health care obtaining through the preparation of scientific and reasonable technique and proportioning and preparation method thereof.In order to realize object of the present invention, intend adopting following technical scheme:
One aspect of the present invention relates to a kind of capsule with health care, it is characterized in that described capsule comprises the bulk drug of following weight portion:
40~50 parts of natto powders, 35~40 parts of dietary fibers, 5~10 parts of ginkgo biloba extracts, 10~15 parts of kudzu-vine root powder;
And pharmaceutically acceptable auxiliary material; Preferably, described ginkgo biloba extract is dry ginnol extract.
In a preferred embodiment of the present invention, described dietary fiber is the dietary fiber that asparagus or asparagus leftover bits and pieces prepare.
In a preferred embodiment of the present invention, described dietary fiber prepares as follows: by the processing of asparagus leftover bits and pieces drying, cross 40 mesh sieves after ultramicro grinding, make asparagus powder;
Take 100 weight portion asparagus powders, add 800-1200 weight portion purified water, stir; After 5-7 weight portion lipase is fully dissolved by purified water, adding in above-mentioned asparagus powder, is to act on 1.5-2.5h under 9.0~9.5,35 ℃ of conditions in pH value, and enzyme goes out;
Asparagus liquid after above-mentioned lipase enzymolysis is cooled to 40~45 ℃, and adjusting pH value is 6.0~6.5, adds 12-18 weight portion amylase, and after 45 ℃ of effect 3-5h, enzyme goes out;
Asparagus liquid after lipase and amylase enzymolysis is cooled to 40~45 ℃, and adjust pH 7.0~7.5, adds 12-18 weight portion protease effect 0.8-1.2h, enzyme goes out, then filter with four layers of gauze, after filter residue water cleans, dry and obtain dietary fiber.
In another preferred embodiment of the present invention, described natto powder prepares as follows:
The making of freeze dry powder of fermented soybean: choose full grains, soya bean of uniform size, after soaking, autoclave sterilization pot 25-35min processes, and natto subject to sterilization is cooled to 40 ℃ of appropriate Bacillus natto seed liquor of following rear inoculation under suitable temperature and humidity, to cultivate 20-28h and obtains fresh natto; 200 mesh sieves were pulverized in the natto freeze drying fermenting, and obtained freeze-dried powder.
In a preferred embodiment of the present invention, described Bacillus natto seed liquor is that deposit number is the Bacillus natto seed liquor of CGMCCNO.7168.
The present invention also relates to above-mentioned capsule on the other hand in the purposes of preparing in medicine or health products, described medicine or health products for cardiovascular and cerebrovascular disease, change human enteric bacteria grow thickly state, alleviate constipation, lipopenicillinase, step-down, fall fire, clearing heat and detoxicating and/or chest enlarge.
The natto powder that the present invention uses can make by the present invention's processing; Dietary fiber used can be by preparing in asparagus or asparagus leftover bits and pieces; Ginkgo biloba p.e, kudzu-vine root powder can be bought and obtain on market.Bacillus natto HT8 deposit number is that this bacterial strain of CGMCCNO.7168(has been documented in Chinese patent application 201310161221.2,201310681770.2,201310681809.0 in), be preserved in common micro-organisms culture presevation administrative center of China Committee for Culture Collection of Microorganisms.
Technical scheme of the present invention:
1. the making of freeze dry powder of fermented soybean: choose full grains, soya bean of uniform size, after soaking, autoclave sterilization pot 30min processes, and natto subject to sterilization is cooled to 40 ℃ of appropriate Bacillus natto seed liquor of following rear inoculation under suitable temperature and humidity, to cultivate 24h and obtains fresh natto.200 mesh sieves were pulverized in the natto freeze drying fermenting, and obtained freeze-dried powder.
2. the preparation of dietary fiber: by asparagus or its leftover bits and pieces drying processing, cross 40 mesh sieves after ultramicro grinding, make asparagus powder.Asparagus powder is by four layers of filtered through gauze after lipase, amylase, protease hydrolyzed digestion, and filter residue cleaning, drying obtains dietary fiber.
3. press 40~50 parts of natto powders, 35~40 parts of dietary fibers, 5~10 parts of ginkgo biloba extracts, the weight ratio that kudzu-vine root powder is 10~15 parts mixes dress capsule, the filling 250mg of every capsules.
The present invention has following beneficial effect:
The healthy food that these four kinds of natto powder, dietary fiber, ginkgo biloba extract and kudzu-vine root powder are had better nutritivity health care value by the present invention is fused together, produce a kind of capsule product that abundant nutrition is worth that has, there is good nutrition and health care effect, and take simple and conveniently, frozen dried natto has retained nutrition and the functional component of natto to the full extent; Product has control cardiovascular and cerebrovascular disease, change the human enteric bacteria state of growing thickly, help digest, alleviate constipation, lipopenicillinase, step-down, fall fire, the effect such as clearing heat and detoxicating, women's cosmetology and health, chest enlarge etc. are had to special efficacy simultaneously, and avoided natto, kudzu-vine root powder, the impact of asparagus on consumer taste.
Microorganism information
The Bacillus natto HT8 bacillus subtilis (Bacillus subtilis) using in a preferred embodiment of the present invention and the specific embodiment has been preserved in China Committee for Culture Collection of Microorganisms's common micro-organisms center, deposit number CGMCCNO.7168, preservation address is: No. 3, Yard 1, BeiChen xi Road, Chaoyang District, Beijing City, Institute of Microorganism, Academia Sinica, preservation date is 2013.1.18.
The specific embodiment
Illustrate in greater detail embodiment of the present invention below in conjunction with subordinate list and embodiment.But enforcement of the present invention is not limited to the following stated, any pro forma accommodation that the present invention is made and/or change all will fall into protection domain of the present invention.
In the present invention, if not refer in particular to, all equipment and raw materials etc. all can be buied from market or the industry is conventional.Method in following embodiment, if no special instructions, is the conventional method of this area.
Embodiment 1:
The preparation of freeze dry powder of fermented soybean:
1. the processing of soya bean: choose full grains, soya bean of uniform size, mixes with the ratio of water 1:3 in soya bean, soaks 3h at 30 ℃, drains, then take a certain amount of in small beaker, under autoclave sterilization pot, 121 ℃ of sterilizing 30min, cooling, stand-by.
2. actication of culture: draw 100ul preservation Bacillus natto bacterial classification to 10mlLB culture medium, 37 ℃, 200r/min cultivates 12h, for subsequent use in Refrigerator store.
3. the preparation of seed liquor: get the activation HT8 bacterial classification of 200ul to 20ml liquid seed culture medium, 37 ℃, 200r/min cultivates 18h.
4. inoculated and cultured: natto subject to sterilization is cooled to, below 40 ℃, HT8 is inoculated in soya bean with 4% inoculum concentration, in 37 ℃, cultivates 24h under 90% relative humidity.
Freeze-dried powder make: first by the natto fermenting in-20 ℃ of pre-freezes, in-60 ℃ of vacuum freeze drying 24h, then frozen dried natto was pulverized to 200 mesh sieves, obtain freeze-dried powder.
The preparation of dietary fiber:
1. by the processing of asparagus leftover bits and pieces drying, after ultramicro grinding, cross 40 mesh sieves, make asparagus powder.
2. take 100g asparagus powder, add 1000ml purified water, stir.After 6g lipase is fully dissolved by a small amount of purified water, adding in above-mentioned asparagus powder, is to act on 2h under 9.0~9.5,35 ℃ of conditions in pH value, and enzyme goes out;
3. the asparagus liquid after above-mentioned lipase enzymolysis is cooled to 40~45 ℃, adjusting pH value is 6.0~6.5, adds 15g amylase, and after 45 ℃ of effect 4h, enzyme goes out;
4. the asparagus liquid after lipase and amylase enzymolysis is cooled to 40~45 ℃, adjust pH 7.0~7.5, adds 15g protease effect 1h, and then the enzyme that goes out filters with four layers of gauze, after filter residue water cleans, dries and obtain dietary fiber.
5. according to following quality proportioning: 50 parts of natto powders, 35 parts of dietary fibers, 5 parts of ginkgo ethanol extracts, 10 parts of kudzu-vine root powder.Filling capsule after mixing, every 250mg.
Embodiment 2:
Prepare natto powder and dietary fiber according to method in embodiment 1, mix a component by following constituent mass proportioning: 45 parts of natto powders, 40 parts of reed food fibers, 5 parts of ginkgo biloba extracts, 10 parts of kudzu-vine root powder, filling capsule, every 250mg.
Embodiment 3:
Prepare natto powder and dietary fiber according to method in embodiment 1, mix a component by following constituent mass proportioning: 45 parts of natto powders, 35 parts of dietary fibers, 5 parts of ginkgo biloba extracts, 15 parts of kudzu-vine root powder, filling capsule, every 250mg.
Pharmacodynamic experiment embodiment 1:
Natto dietary fiber Capsule in Rats regulating blood lipid action:
Natto dietary fiber capsule formula used is each constituent mass proportioning used in embodiment 1.According to " function of health food is learned assessment process and the method for inspection " 2003 auxiliary adjustment of blood fat methods.Select 50 of clean level Wistar kind male rats, body weight 200~250g, afterbody is got the content of blood survey serum total cholesterol (TC) and triglycerides (TG), be divided at random 5 groups according to TC level, be basic, normal, high 3 dosage groups, negative control group and the high fat control group of tested material.Except negative control group, other each group all gives high lipid food and feeds.The dosage of 3 dosage groups is respectively 165mg/kg, 495mg/kg, 990mg/kg (being respectively 5 times, 15 times, 30 times amounts of human body RD), all give tested material by 1ml/100g per os every day gavage, negative control group and high fat control group give same volume pure water.After gavage 30d, put to death animal continuously, measure serum TC, TG index.
Result is as shown in table 1, and natto dietary fiber capsule has the effect that reduces TC and TG in rat blood serum.With the comparison of high fat control group, to take TC content in the rear rat blood serum of low dosage capsule (165mg/kg) and significantly reduce (P<0.05), TG content extremely significantly reduces (P<0.01).
Compared with negative control group,
#p<0.05,
##p<0.01; Compared with high fat control group,
*p<0.05,
*p<0.01.
Pharmacodynamic experiment embodiment 2:
The effect of natto dietary fiber capsule to mouse defecation:
Natto dietary fiber capsule formula used is each constituent mass proportioning used in embodiment 1.Get fasting, can't help 50 of water 12h adult mices, be divided at random 5 groups, be made as physiological saline control group, small dose group (165mg/kg), middle dosage group (485mg/kg), heavy dose of group (990mg/kg) and positive controls (2.5mg/ml phenolphthalein solution), every group 10, physiological saline and medicine all configure with 50% burnt black ink.Mouse was put into metabolic cage in after administration 30 minutes, observed and recorded mouse is arranged the time of melena for the first time, and stool in mice of collection per hour, and 5h continuously calculates the grain number of stool in mice in 5h, and records the shape of ight soil.
Note: with the comparison of physiological saline group, * p<0.05, * * p<0.01.
Result is as shown in table 2, and natto dietary fiber capsule can accelerate mouse defecation, shortens the time of first grain row melena.With the comparison of physiological saline group, first grain row melena time shorten is the heavy dose of group of 92.4min(), there is significant difference (p<0.05); In unit interval, the number of times of mouse defecation also obviously increases, and the water content of ight soil also obviously increases.
Illustrate: the dietary fiber in the present invention can derive from the leftover bits and pieces producing in other plant of being rich in dietary fiber or its process.
The above, be only the specific embodiment of the present invention, but protection scope of the present invention is not limited to this, and any variation of expecting without creative work or replacement, within all should being encompassed in protection scope of the present invention.Therefore, protection scope of the present invention should be as the criterion with the protection domain that claims were limited.
Claims (6)
1. there is a capsule for health care, it is characterized in that described capsule comprises the bulk drug of following weight portion:
40~50 parts of natto powders, 35~40 parts of dietary fibers, 5~10 parts of ginkgo biloba extracts, 10~15 parts of kudzu-vine root powder;
And pharmaceutically acceptable auxiliary material; Preferably, described ginkgo biloba extract is dry ginnol extract.
2. capsule according to claim 1, described dietary fiber is the dietary fiber that asparagus or asparagus leftover bits and pieces prepare.
3. capsule according to claim 2, described dietary fiber prepares as follows: by the processing of asparagus leftover bits and pieces drying, cross 40 mesh sieves after ultramicro grinding, make asparagus powder;
Take 100 weight portion asparagus powders, add 800-1200 weight portion purified water, stir; After 5-7 weight portion lipase is fully dissolved by purified water, adding in above-mentioned asparagus powder, is to act on 1.5-2.5h under 9.0~9.5,35 ℃ of conditions in pH value, and enzyme goes out;
Asparagus liquid after above-mentioned lipase enzymolysis is cooled to 40~45 ℃, and adjusting pH value is 6.0~6.5, adds 12-18 weight portion amylase, and after 45 ℃ of effect 3-5h, enzyme goes out;
Asparagus liquid after lipase and amylase enzymolysis is cooled to 40~45 ℃, and adjust pH 7.0~7.5, adds 12-18 weight portion protease effect 0.8-1.2h, enzyme goes out, then filter with four layers of gauze, after filter residue water cleans, dry and obtain dietary fiber.
4. according to the capsule described in claim 1-3 any one, described natto powder prepares as follows:
The making of freeze dry powder of fermented soybean: choose full grains, soya bean of uniform size, after soaking, autoclave sterilization pot 25-35min processes, and natto subject to sterilization is cooled to 40 ℃ of appropriate Bacillus natto seed liquor of following rear inoculation under suitable temperature and humidity, to cultivate 20-28h and obtains fresh natto; 200 mesh sieves were pulverized in the natto freeze drying fermenting, and obtained freeze-dried powder.
5. capsule according to claim 4, described Bacillus natto seed liquor is that deposit number is the Bacillus natto seed liquor of CGMCCNO.7168.
6. the capsule described in claim 1-5 any one is in the purposes of preparing in medicine or health products, described medicine or health products for cardiovascular and cerebrovascular disease, change human enteric bacteria grow thickly state, alleviate constipation, lipopenicillinase, step-down, fall fire, clearing heat and detoxicating and/or chest enlarge.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410029675.9A CN103766904A (en) | 2014-01-22 | 2014-01-22 | Preparation of capsule with function of lowering lipid and facilitating feces excretion and application of capsule |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410029675.9A CN103766904A (en) | 2014-01-22 | 2014-01-22 | Preparation of capsule with function of lowering lipid and facilitating feces excretion and application of capsule |
Publications (1)
Publication Number | Publication Date |
---|---|
CN103766904A true CN103766904A (en) | 2014-05-07 |
Family
ID=50560027
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410029675.9A Pending CN103766904A (en) | 2014-01-22 | 2014-01-22 | Preparation of capsule with function of lowering lipid and facilitating feces excretion and application of capsule |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103766904A (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104256583A (en) * | 2014-09-05 | 2015-01-07 | 洛阳华以生物工程有限公司 | Formula of health-care product adopting natto freeze-dried powder and ginkgo biloba extract as main materials |
CN105124445A (en) * | 2015-09-28 | 2015-12-09 | 陈薇 | Detoxifying and fire purging natto powder and preparing method |
CN105456050A (en) * | 2015-12-31 | 2016-04-06 | 青岛美博生物技术有限公司 | Freeze-dried powder, essence and skincare set for repairing acne marks and scars |
CN105661335A (en) * | 2016-02-25 | 2016-06-15 | 贵州秀生堂医药生物有限公司 | Preparation method of natto enteric capsule functional food |
CN107041865A (en) * | 2016-02-05 | 2017-08-15 | 重庆井谷元食品科技有限公司 | A kind of natto particle with beauty functions and preparation method thereof |
CN107997157A (en) * | 2017-12-01 | 2018-05-08 | 宋波 | Quick-freezing type food containing Nattokinase |
CN110584097A (en) * | 2019-09-23 | 2019-12-20 | 黑龙江八一农垦大学 | Meal replacement powder and preparation method and application thereof |
CN112753923A (en) * | 2021-01-19 | 2021-05-07 | 中华全国供销合作总社济南果品研究院 | Peony pistil ultrafine powder solid beverage and preparation method thereof |
CN114403388A (en) * | 2022-01-19 | 2022-04-29 | 安徽工程大学 | Double-strain fermentation functional flavor type dried bamboo shoots and preparation method thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1736252A (en) * | 2005-07-14 | 2006-02-22 | 上海诺金科生物科技有限公司 | Process for preparing freeze dry powder of fermented soybean |
CN1814274A (en) * | 2005-12-21 | 2006-08-09 | 张恩及 | Health-care product for treating cardiovascular and cerebralvascular disease |
CN101062086A (en) * | 2006-04-27 | 2007-10-31 | 黑龙江省祖研北药科技开发有限责任公司 | Composite medicine for reducing blood pressure and dissolving thrombus and its preparing process |
CN101117630A (en) * | 2006-07-31 | 2008-02-06 | 北京小西保健食品有限公司 | Preparation method of nattokinase powder and natto Brazil mushroom capsule |
CN102488721A (en) * | 2011-12-14 | 2012-06-13 | 广东长兴科技保健品有限公司 | Preparation method for ginkgo leaf extracts and preparation of ginkgo leaf extracts |
CN102885306A (en) * | 2012-10-12 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | Health-care food composite with function of assisting in reducing blood fat and preparation method thereof |
CN103223033A (en) * | 2013-05-22 | 2013-07-31 | 武汉真福医药科技发展有限公司 | Novel natto health-care composite and preparation method and application thereof |
-
2014
- 2014-01-22 CN CN201410029675.9A patent/CN103766904A/en active Pending
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1736252A (en) * | 2005-07-14 | 2006-02-22 | 上海诺金科生物科技有限公司 | Process for preparing freeze dry powder of fermented soybean |
CN1814274A (en) * | 2005-12-21 | 2006-08-09 | 张恩及 | Health-care product for treating cardiovascular and cerebralvascular disease |
CN101062086A (en) * | 2006-04-27 | 2007-10-31 | 黑龙江省祖研北药科技开发有限责任公司 | Composite medicine for reducing blood pressure and dissolving thrombus and its preparing process |
CN101117630A (en) * | 2006-07-31 | 2008-02-06 | 北京小西保健食品有限公司 | Preparation method of nattokinase powder and natto Brazil mushroom capsule |
CN102488721A (en) * | 2011-12-14 | 2012-06-13 | 广东长兴科技保健品有限公司 | Preparation method for ginkgo leaf extracts and preparation of ginkgo leaf extracts |
CN102885306A (en) * | 2012-10-12 | 2013-01-23 | 中科乐仁(北京)科技发展有限公司 | Health-care food composite with function of assisting in reducing blood fat and preparation method thereof |
CN103223033A (en) * | 2013-05-22 | 2013-07-31 | 武汉真福医药科技发展有限公司 | Novel natto health-care composite and preparation method and application thereof |
Non-Patent Citations (3)
Title |
---|
冯翠萍 等: "酶法提取芦笋皮中高活性膳食纤维的研究", 《农业工程学报》 * |
陈明玉 等: "三清降脂胶囊的降血脂作用及毒性研究", 《延边大学医学学报》 * |
顾振新 等: "芦笋弃料的营养价值和开发利用研究", 《南京农业大学学报》 * |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104256583A (en) * | 2014-09-05 | 2015-01-07 | 洛阳华以生物工程有限公司 | Formula of health-care product adopting natto freeze-dried powder and ginkgo biloba extract as main materials |
CN105124445A (en) * | 2015-09-28 | 2015-12-09 | 陈薇 | Detoxifying and fire purging natto powder and preparing method |
CN105456050A (en) * | 2015-12-31 | 2016-04-06 | 青岛美博生物技术有限公司 | Freeze-dried powder, essence and skincare set for repairing acne marks and scars |
CN107041865A (en) * | 2016-02-05 | 2017-08-15 | 重庆井谷元食品科技有限公司 | A kind of natto particle with beauty functions and preparation method thereof |
CN105661335A (en) * | 2016-02-25 | 2016-06-15 | 贵州秀生堂医药生物有限公司 | Preparation method of natto enteric capsule functional food |
CN107997157A (en) * | 2017-12-01 | 2018-05-08 | 宋波 | Quick-freezing type food containing Nattokinase |
CN110584097A (en) * | 2019-09-23 | 2019-12-20 | 黑龙江八一农垦大学 | Meal replacement powder and preparation method and application thereof |
CN112753923A (en) * | 2021-01-19 | 2021-05-07 | 中华全国供销合作总社济南果品研究院 | Peony pistil ultrafine powder solid beverage and preparation method thereof |
CN112753923B (en) * | 2021-01-19 | 2022-11-22 | 中华全国供销合作总社济南果品研究院 | Peony pistil superfine powder solid beverage and preparation method thereof |
CN114403388A (en) * | 2022-01-19 | 2022-04-29 | 安徽工程大学 | Double-strain fermentation functional flavor type dried bamboo shoots and preparation method thereof |
CN114403388B (en) * | 2022-01-19 | 2023-09-19 | 安徽工程大学 | Double-strain fermentation functional flavor dried bamboo shoots and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103766904A (en) | Preparation of capsule with function of lowering lipid and facilitating feces excretion and application of capsule | |
CN104824548B (en) | Matrimony vine compound health ferment and preparation method thereof | |
CN103027231B (en) | Compound probiotics fermented Chinese herbal medicine active health care liquid and preparation method thereof | |
CN103478738B (en) | A kind of composition with fat-reducing body shaping and Weight management effect | |
CN105918821A (en) | Compound enzyme liquid having effects of lowering high blood lipids, high blood pressure and high blood sugar, and improving immunity, and preparation method thereof | |
CN108272073A (en) | A kind of weight losing meal-replacing powder and preparation method thereof | |
CN106798252B (en) | Natto product with effects of regulating intestines and stomach, reducing blood fat and dissolving thrombus | |
CN104305207B (en) | The formula of a kind of Chinese medicine composite enzyme and its preparation method | |
CN102367418B (en) | Traditional Chinese medicine probiotics liquid medium used for pig feed, culturing method and feed additive | |
CN110521785A (en) | Probiotics fermention functional food and its preparation | |
CN106858579A (en) | Prepare the fermentation composition and preparation method of the plant enzyme for being applied to diabetes conditioning and routine servicing | |
CN107019211A (en) | Prepare the fermentation composition and preparation method of the plant enzyme with the strong renal function of kidney tonifying | |
CN111329055B (en) | Preparation method of trifoliate acanthopanax enzyme | |
CN106858577A (en) | Prepare the fermentation composition and preparation method of the plant enzyme with liver protecting, the fatty subtotal hepatectomy of regulation | |
CN105962378A (en) | Preparation method of active lactobacillus preparation containing hericium polysaccharides | |
CN105685972A (en) | Probiotics composition with fat reducing function and preparation method and application thereof | |
CN102021101B (en) | Preparation method of healthy wine for preventing and treating cardiovascular and cerebrovascular diseases | |
CN105685620A (en) | Moringa oleifera oral liquid and preparation method thereof | |
CN104522750A (en) | Alga healthcare food | |
WO2019100540A1 (en) | Method for preparing litopenaeusvannamei feed additive | |
CN107212392A (en) | A kind of full nutrition fermentation health-preserving food and preparation method thereof | |
CN106983146A (en) | Prepare the fermentation composition and preparation method of the plant enzyme with conditioning and enhancing human detoxification moistening face | |
CN106880040A (en) | Prepare the fermentation composition and preparation method with the plant enzyme suitable for the conditioning maintenance of rheumatism osteoarthritis patients | |
CN106974263A (en) | A kind of energy lowering blood-fat and reducing weight, the preparation method of compound probiotic plant enzyme powder | |
CN105497106A (en) | Traditional Chinese medicine compound fermentation powder and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20140507 |